February 4, 2010 ALBUQUERQUE, N.M. – Bob Cashman, director of new business development at OsoBio, has been appointed to the board of directors at the PDE: A Pharmaceutical Trade Association.
As the nation’s oldest active trade association, the PDE serves pharmaceutical manufacturers, allied trade industries and pharmacy schools. It also provides a forum for interaction, communication and education among members.
“This appointment to the PDE board clearly reflects the tremendous knowledge and experience Bob has gained working within the pharmaceutical industry,” said Stuart Rose, president and CEO of OsoBio. “OsoBio – and the clients we serve – are fortunate to have Bob working on our behalf every day.”
OSO BioPharmaceuticals Manufacturing, LLC, is a contract manufacturing organization focusing on biologic and pharmaceutical injectables. Headquartered in Albuquerque, N.M., OsoBio specializes in products requiring complex handling, including highly potent compounds. Responsiveness, attention to detail and clear communication are the hallmarks of our client care.
OsoBio surpasses quality–assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.